-
BRD4770: G9a Histone Methyltransferase Inhibitor in Cancer R
2026-04-30
BRD4770, a selective G9a histone methyltransferase inhibitor from APExBIO, enables precise epigenetic modulation in cancer research, particularly for dissecting tumorigenesis and senescence in pancreatic and breast cancer models. This article delivers actionable workflows, troubleshooting strategies, and advanced applications, helping researchers maximize BRD4770’s impact in real-world experimental settings.
-
Tofacitinib (CP-690550): Repairing Inflammation via JAK-STAT
2026-04-30
Discover how Tofacitinib (CP-690550) advances immune modulation research by uniquely targeting mitochondrial dysregulation and inflammation in GM-CSF-driven macrophage pathology. This article unveils new mechanistic insights for assay optimization and translational strategies.
-
Selective Nanomolar IRAP Inhibitors via α-Hydroxy-β-Amino Be
2026-04-29
This study presents a highly selective, cell-active nanomolar inhibitor of insulin-regulated aminopeptidase (IRAP) derived from α-hydroxy-β-amino acid modifications of bestatin. By leveraging structural biology and refined synthetic methods, the work establishes new chemical tools for dissecting M1 aminopeptidase function, with implications for immune modulation and inhibitor development.
-
Adefovir (GS-0393): Applied Protocols for HBV & OAT1 Researc
2026-04-29
Adefovir (GS-0393) stands out as a dual-purpose agent in hepatitis B virus research and as a precision probe for renal transporter studies. This guide details applied workflows, troubleshooting strategies, and the latest cross-domain insights to maximize reproducibility and data clarity in advanced virology and transporter labs.
-
EZ Cap™ Cy5 EGFP mRNA (5-moUTP): Precision Tracking in mRNA
2026-04-28
Explore how EZ Cap™ Cy5 EGFP mRNA (5-moUTP) advances mRNA delivery and translation efficiency assays with dual-fluorescent tracking and immune suppression. This article uncovers new assay strategies and integrates cutting-edge insights from redox-responsive delivery systems.
-
UTP Solution: Optimizing In Vitro Transcription and RNA Assa
2026-04-28
APExBIO's UTP Solution (100 mM) delivers unmatched purity and reliability for high-sensitivity RNA workflows. This guide bridges cutting-edge epigenetic insights with actionable protocol enhancements and troubleshooting strategies, empowering researchers to maximize assay reproducibility and experimental precision.
-
G007-LK Tankyrase 1/2 Inhibitor: Quantitative Insights for C
2026-04-27
Explore how G007-LK, a potent tankyrase 1/2 inhibitor, enables quantitative modulation of Wnt/β-catenin signaling and β-catenin degradation in APC mutation colorectal cancer research. This article delivers protocol-ready metrics, critical assay guidance, and new perspectives beyond established reviews.
-
Patient-Derived Gastric Cancer Assembloids Reveal Stromal Im
2026-04-27
This study introduces a patient-derived gastric cancer assembloid model that integrates matched tumor organoids with diverse stromal cell subpopulations, enabling a physiologically relevant platform for dissecting tumor–stroma interactions and drug resistance. The model provides critical insights for personalized therapy development and highlights the significant influence of the microenvironment on drug response.
-
Elucidating Metabolite Regulation of TET2 Dioxygenase Activi
2026-04-26
This article reviews a protocol combining biochemical assays and saturation transfer difference NMR to validate metabolite binding and regulatory effects on human TET2 dioxygenase. The approach enables identification of both activating and inhibitory metabolites, providing a framework for dissecting how cellular metabolism influences epigenetic enzyme activity.
-
MK 0893: Glucagon Receptor Antagonist for Diabetes Research
2026-04-25
MK 0893 empowers translational researchers with nanomolar precision to dissect glucagon receptor signaling and glucose metabolism in both cellular and animal models. Its validated allosteric mechanism, robust selectivity, and workflow-ready protocols make it a premier choice for type 2 diabetes research and advanced cAMP inhibition assays.
-
Allosteric PDK4 Inhibitors: Advances for Metabolic Disease T
2026-04-24
This article examines the discovery of novel allosteric pyruvate dehydrogenase kinase 4 (PDK4) inhibitors, focusing on compound 8c's potent in vitro and in vivo activity, favorable metabolic profile, and implications for metabolic diseases and allergy models. The findings illuminate new therapeutic avenues for targeting PDK4 in diabetes, obesity, and related inflammatory conditions.
-
Adefovir (GS-0393): Advanced Workflows in HBV Antiviral Rese
2026-04-24
Adefovir (GS-0393) stands out as a water-soluble, selective DNA polymerase inhibitor, enabling robust hepatitis B virus research and precise transporter studies. This guide translates cutting-edge evidence—including recent clinical insights—into actionable protocols, troubleshooting strategies, and comparative advantages for scientists aiming to optimize HBV antiviral assays.
-
Salinomycin: Polyether Ionophore Antibiotic in HCC Workflows
2026-04-23
Salinomycin, a potent polyether ionophore antibiotic, is redefining hepatocellular carcinoma research by targeting Wnt/β-catenin signaling and drug resistance pathways. This article delivers stepwise protocols, advanced troubleshooting, and practical guidance to maximize experimental reproducibility and anti-cancer efficacy, leveraging APExBIO’s high-purity Salinomycin.
-
L-Alanyl-L-Glutamine (B8228): Practical Lab Guidance & QC
2026-04-23
L-Alanyl-L-Glutamine (SKU B8228) is designed for researchers requiring a stable, water-soluble dipeptide to enhance intestinal barrier function and support cell health in vitro. Its formulation addresses instability issues found in conventional L-glutamine supplements, with clear storage and application protocols. This product is not recommended for applications requiring DMSO or ethanol solubility, or for long-term solution storage.
-
HyperScribe SP6 High Yield RNA Synthesis Kit: Precision for
2026-04-22
The HyperScribe SP6 High Yield RNA Synthesis Kit from APExBIO delivers unmatched yield and flexibility for in vitro transcription workflows, supporting rapid, scalable, and highly customizable RNA production. Its compatibility with advanced probe labeling and RNA modifications makes it a cornerstone for cutting-edge research in RNA interference, vaccine development, and immune response studies.